Latest News

In the last 7 days
Caribou cuts pipeline and workforce to focus on lead CAR-T programmes Pharmaceutical Technology12:11 25-Apr-25
Novel cancer immunotherapy approach could complement existing CAR-T treatments News-Medical.Net03:44 25-Apr-25
Turning immune cells into cancer's worst enemy: China's CAR-T revolution People's Daily06:43 24-Apr-25
Novel humanized CD19-car-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute… Nature.com05:55 24-Apr-25
CPTx Appoints McDavid Stilwell Chief Financial Officer PR Newswire (Press Release)17:58 23-Apr-25
High Response Rate in Myeloma With Novel CAR-T After Anti-BCMA Failure Medpage Today17:48 23-Apr-25
Chimeric Therapeutics Advances CAR-T Trials with New Collaborations and Funding TipRanks02:31 23-Apr-25
DAAN Biotherapeutics and GC Cell agree on CAR-T, CAR-NK therapies Pharmaceutical Technology12:59 22-Apr-25
GC Cell taps new antibody from Korean biotech to boost CAR-T, CAR-NK programs Korea Biomedical Review06:38 22-Apr-25
Korea's DAAN Biotherapeutics and GC Cell join hands to advance CAR-T and CAR-NK cell therapies BioSpectrum Asia10:55 21-Apr-25
DAAN Biotherapeutics and GC Cell Sign Exclusive Technology Transfer Agreement for Tumor… PR Newswire (Press Release)08:36 21-Apr-25
Bringing CAR-T therapy within reach: how decentralised manufacturing will improve patient access Manufacturing Chemist08:01 21-Apr-25
In the last month
Singapore-based BioCell Innovation’s CAR-T process gets funding boost from ScaleReady BioSpectrum Asia10:47 17-Apr-25
Curocell expands CAR-T therapy into autoimmune diseases Korea Biomedical Review09:17 17-Apr-25
Arovella tackles CAR-T’s limitations in cancer treatment with off-the-shelf innovation Stockhead23:08 16-Apr-25
Porton Advanced's End-to-End CDMO Solutions Accelerates IND Approval of Tasly's Innovative… PR Newswire (Press Release)14:00 16-Apr-25
First clinical trial in Korea uses CAR-T cell therapy to treat intractable lupus Korea Biomedical Review02:37 16-Apr-25
Deep insight into cytokine storm: from pathogenesis to treatment Nature.com00:27 16-Apr-25
Do in vivo CAR-T cell therapies have the potential to overtake ex vivo CAR-Ts? Pharmaceutical Technology17:05 15-Apr-25
UAE: Pact to cut $1m cancer treatment costs by 90% Gulf News11:54 15-Apr-25
Belgium’s pharma hub still resilient despite US investment surge EurActiv.com23:48 14-Apr-25
Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T… PR Newswire (Press Release)13:06 14-Apr-25
Curocell to present preclinical data on allogeneic CAR-T therapy for T-cell malignancies at AACR 2025 Korea Biomedical Review07:06 14-Apr-25
FDA clears IND for clinical trial testing switchable CAR-T therapy in patients with autoimmune… ScienceDaily03:08 13-Apr-25
Caring Cross and Burjeel Holdings partner to bring CAR-T therapy to MENA BioSpectrum Asia10:59 11-Apr-25
Insights From HOPA 2025: Pharmacists Discuss CAR-T Safety at a Comprehensive Cancer Center Pharmacy Times00:11 11-Apr-25
Cellares and University of Wisconsin Agree to Automate Clinical-Scale Production of CRISPR-Edited CAR-T Genetic Engineering and Biotechnology News19:55 10-Apr-25
US-Based Caring Cross and Burjeel Holdings Partner to Bring Revolutionary CAR-T Therapy to MENA … PR Newswire (Press Release)16:30 10-Apr-25
Avalon GloboCare Secures Patent for CAR-T Technology TipRanks13:36 10-Apr-25
Cellares and University of Wisconsin School of Medicine and Public Health to Automate… Business Wire (Press Release)12:02 10-Apr-25
Calibr-Skaggs receives FDA approval to test sCAR-T therapy in patients with autoimmune diseases News-Medical.Net03:22 10-Apr-25
Downstream Processing Of A Mid-Scale Lentiviral Vector Batch Drugs Discovery Online06:11 9-Apr-25
CAR-M Technology: A Novel Approach to Overcome CAR-T Limitations in Solid Tumor Treatment Newswise (Press Release)05:09 9-Apr-25
Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European… Nature.com03:40 9-Apr-25
Cartesian Maps Out CAR-T Strategy With Simpler Logistics In Mind Scrip Pharma Intelligence22:36 8-Apr-25
Beyond the Known: Unlocking a New CAR Target for Blood Cancers Behavioural and Social Sciences at Nature Research21:42 8-Apr-25
Nigeria: Nigerian-American Venture Capitalist, Joshua Oduyemi Speaks On Developing Advanced Cancer and Autoimmune… AllAfrica18:54 8-Apr-25
Q&A: Artiva allogeneic NK cell therapies for treating autoimmune disease European Pharmaceutical Manufacturer16:38 8-Apr-25
[ICKSH 2025] CAR-T therapy reshapes lymphoma treatment amid new strategies and resistance challenges Korea Biomedical Review09:42 8-Apr-25
CAR-T developer Lyell lays off 73 ImmPact staffers, shutters LA facility shortly after… FiercePharma21:09 7-Apr-25
Dad who almost had 'final Christmas' with incurable cancer saved by miracle treatment Plymouth Live15:41 7-Apr-25
Dad with incurable cancer who was 'practically dead' saved by miracle treatment The Mirror14:37 7-Apr-25
Cancer Therapeutics Market to Reach $168 Billion by 2029 Driven by Metastatic and Recurrent Cancer Innovations GlobeNewswire (Press Release)11:29 7-Apr-25
Emerging T-cell lymphomas after car T-cell therapy Nature.com09:03 7-Apr-25
Scots dad with incurable cancer saved by life-saving new trial treatment Edinburgh Live07:31 7-Apr-25
Scots dad who was 'practically dead' from incurable cancer saved by miracle treatment Daily Record04:43 7-Apr-25
LILRB1-directed car-T cells for the treatment of hematological malignancies Nature.com01:55 5-Apr-25
Radiation Bridging Therapy Boosts CAR T Outcomes in R/R LBCL American Journal of Managed Care20:42 3-Apr-25
IO360 Summit: Improving CAR-T cell therapy manufacture and accessibility Pharmaceutical Technology16:50 3-Apr-25
IO360 summit: CAR-T cell therapy applications beyond blood cancer Pharmaceutical Technology16:29 3-Apr-25
Nivolumab May Restore T-Cell Fitness Following CAR T-Cell Therapy in Patients With Multiple Myeloma Pharmacy Times14:14 3-Apr-25
Glofitamab in refractory or relapsed diffuse large B cell lymphoma after failing car-T cell therapy: a phase 2 Lysa… Nature.com10:14 3-Apr-25
Hemogenyx Pharmaceuticals Advances CAR-T Therapy with FDA IND Report Submission TipRanks07:10 3-Apr-25
CAR-T cancer treatment available in the Capital Region for the first time WAMC17:13 2-Apr-25
Marker Therapeutics Reports Year-End 2024 Corporate and Financial Results GlobeNewswire (Press Release)13:52 31-Mar-25
Transformations in Drug Development for Cell and Gene Therapies PharmTech.com14:21 28-Mar-25
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang PharmTech.com14:21 28-Mar-25

      
            
      
    view more headlines
   
      
      
      
25 Apr 12:11
   

About our CAR-T news

Latest news on CAR-T (Chimeric Antigen Receptor T-cell) therapy, a type of cancer treatment that involves modifying patients' T-cells to recognize and attack cancer cells. In this therapy, T-cells are collected from the patient, engineered in a lab to express a specific receptor that binds to a protein on cancer cells, and then infused back into the patient to fight the cancer. CAR-T therapies have shown promise in treating certain types of blood cancers, like lymphoma and leukemia.

CAR-T

Latest News

About our CAR-T news

Cancer Top Stories

Health Top Stories

UK Top Stories

World Top Stories